REIMBURSEMENT UNRAVELLED: Convincing UK medtech buyers
This article was originally published in Clinica
Executive Summary
In the second article of Clinica’s new reimbursement series, Dr Mark Charny of UK consultancy Translucency throws more light at the volume and type of evidence that is needed to encourage the uptake of medical devices by buyers in the UK